MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    A randomized, double-blind, placebo-controlled trial of deutetrabenazine for the treatment of tardive dyskinesia (ARM-TD)

    H.H. Fernandez, S.A. Factor, R.A. Hauser, J. Jimenez-Shahed, W. Ondo, M.S. LeDoux, D. Shprecher, T. Simuni, D. Stamler, K.E. Anderson (Cleveland, OH, USA)

    Objective: To determine the efficacy and safety of deutetrabenazine (DTB) as a treatment for tardive dyskinesia (TD). Background: There is no approved treatment for TD,…
  • 2016 International Congress

    Psychiatric profile in functional (psychogenic) jerky movement disorders

    Y.E.M. Dreissen, T.J. van Trier, J.M. Dijk, D.C. Cath, M.A.J. Tijssen (Amsterdam, Netherlands)

    Objective: To systematically assess the psychiatric profile in functional jerky movement disorders. Background: Less and less emphasis is currently placed on psychopathology in functional neurologic…
  • 2016 International Congress

    Augmentation and impulse control disorders in restless legs syndrome – Coexistence or association?

    B. Heim, L. Zamarian, A. Heidbreder, A. Stefani, M.T. Pertl, E. Brandauer, K. Seppi, M. Delazer, W. Poewe, B. Högl, A. Djamshidian (Innsbruck, Austria)

    Objective: To assess the frequency of impulse control disorders (ICDs) in patients with restless legs syndrome (RLS) with and without augmentation under dopaminergic therapy. Background:…
  • 2016 International Congress

    Children with idiopathic tics reveal additional features of hyperkinetic movement disorders

    P.F. Sinnige, R. Brandsma, W. Eggink, M.J. Kuiper, I.J. Lunsing, M. Boon, C.C.S. Delnooz, M.E. van Egmond, O.G.F. Sinnige, J.J. de Vries, P.J. Hoekstra, D.A. Sival (Groningen, Netherlands)

    Objective: To investigate whether children with tics reveal features of additional hyperkinetic movement disorders. Background: The patho-physiology for idiopathic tic disorders is unknown, although underlying…
  • 2016 International Congress

    Orthostatic tremor: Is deep brain stimulation better than spinal cord stimulation?

    H.L. Chiang, Y. Tai, V.S.C. Fung, N. Mahant (Sydney, Australia)

    Objective: To describe 2 patients with orthostatic tremor (OT) who responded to deep brain stimulation (DBS). Background: OT is a rare movement disorder, characterized by…
  • 2016 International Congress

    Increase L-dopa dosage for rest tremor or think about the essential tremor too?

    A. Voskanyan, G. Avagyan, E. Khachatryan, K. Harutyunyan, S. Khachaturyan, H. Amirjanyan, H. Manvelyan (Yerevan, Armenia)

    Objective: A 57-year old man with hand tremor is diagnosed with Parkinson's disease (PD) and treated with high dose levodopa (L-dopa) during last 5 years,…
  • 2016 International Congress

    Towards a responsive deep brain stimulation for the treatment of essential tremor

    E. Opri, J. Shute, R. Molina, M. Okun, A. Gunduz, K. Foote (Gainesville, FL, USA)

    Objective: To identify neurophysiologic markers of intention tremor in the ventral intermediate thalamic nucleus (Vim) and hand motor cortex to develop closed-loop deep brain stimulation…
  • 2016 International Congress

    The scale for assessment and rating of ataxia in early onset ataxia; always a reliable biomarker?

    R. Brandsma, T.F. Lawerman, M.J. Kuiper, I.J. Lunsing, H. Burger, D.A. Sival (Groningen, Netherlands)

    Objective: To determine the reliability and discriminant validity of the Scale for Assessment and Rating of Ataxia (SARA) in early onset ataxia. Background: Early onset…
  • 2016 International Congress

    Depression and clinical progression in spinocerebellar ataxias

    S.H. Kuo, R.Y. Lo, K.P. Figueroa, S.M. Pulst, S. Perlman, G. Wilmot, C. Gomez, J. Schmahmann, H. Paulson, V.G. Shakkottai, S. Ying, T. Zesiewicz, K. Bushara, M. Geschwind, G. Xia, T. Ashizawa, S.H. Subramony (New York, NY, USA)

    Objective: To study the prevalence and influence of depressive symptoms in spinocerebellar ataxias (SCAs). Background: Depression is a common comorbidity in SCAs but its association…
  • 2016 International Congress

    Clinico-genetic correlation in Indian spinocerebellar ataxia (SCA1) patients

    A. Takkar, I. Ahmed, S. Shakya, V. Suroliya, R. Singh, A. Sonkar, A.K. Srivastava, M. Faruq (New Delhi, India)

    Objective: To report the Clinico-genetic correlation in Spinocerebellar ataxia type 1 (SCA1) Patients in Indian Population. Background: Spinocerebellar ataxia type 1(SCA1) is a neurodegenerative disease…
  • « Previous Page
  • 1
  • …
  • 82
  • 83
  • 84
  • 85
  • 86
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley